ATE239481T1 - Filmueberzogene tabletten von oxacarbazepin - Google Patents

Filmueberzogene tabletten von oxacarbazepin

Info

Publication number
ATE239481T1
ATE239481T1 AT98908091T AT98908091T ATE239481T1 AT E239481 T1 ATE239481 T1 AT E239481T1 AT 98908091 T AT98908091 T AT 98908091T AT 98908091 T AT98908091 T AT 98908091T AT E239481 T1 ATE239481 T1 AT E239481T1
Authority
AT
Austria
Prior art keywords
oxacarbazepine
film
coated tablets
tablets
coated
Prior art date
Application number
AT98908091T
Other languages
English (en)
Inventor
Burkhard Schluetermann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4184588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE239481(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE239481T1 publication Critical patent/ATE239481T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT98908091T 1997-02-14 1998-02-12 Filmueberzogene tabletten von oxacarbazepin ATE239481T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH33197 1997-02-14
PCT/EP1998/000794 WO1998035681A1 (en) 1997-02-14 1998-02-12 Oxacarbazepine film-coated tablets

Publications (1)

Publication Number Publication Date
ATE239481T1 true ATE239481T1 (de) 2003-05-15

Family

ID=4184588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908091T ATE239481T1 (de) 1997-02-14 1998-02-12 Filmueberzogene tabletten von oxacarbazepin

Country Status (31)

Country Link
US (2) US20070036863A1 (de)
EP (1) EP0966287B1 (de)
JP (3) JP2000511935A (de)
KR (3) KR19980071337A (de)
CN (2) CN1170542C (de)
AR (1) AR011142A1 (de)
AT (1) ATE239481T1 (de)
AU (1) AU738030B2 (de)
BR (1) BR9807368A (de)
CA (1) CA2277791C (de)
CO (1) CO4920215A1 (de)
CY (1) CY2480B1 (de)
CZ (1) CZ298840B6 (de)
DE (1) DE69814367T2 (de)
DK (1) DK0966287T3 (de)
ES (1) ES2199422T3 (de)
HU (1) HU227807B1 (de)
ID (1) ID22348A (de)
MY (1) MY117582A (de)
NO (1) NO327486B1 (de)
NZ (1) NZ336946A (de)
PE (1) PE58999A1 (de)
PL (1) PL193332B1 (de)
PT (1) PT966287E (de)
RU (1) RU2201218C2 (de)
SK (1) SK284503B6 (de)
TR (1) TR199901804T2 (de)
TW (1) TW529957B (de)
UY (1) UY24888A1 (de)
WO (1) WO1998035681A1 (de)
ZA (1) ZA981205B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
PL371259A1 (pl) 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
MXPA06002392A (es) 2003-09-03 2006-06-20 Novartis Ag Uso de oxcarbazepina para el tratamiento de dolor neuropatico diabetico y la mejora del sueno.
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
US8367105B2 (en) 2004-11-10 2013-02-05 Teva Pharmaceutical Industries, Ltd. Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
CN103893145A (zh) 2005-09-23 2014-07-02 弗·哈夫曼-拉罗切有限公司 新型制剂
EP1945632B1 (de) 2005-11-08 2013-09-18 Vertex Pharmaceuticals Incorporated Heterozyklische modulatoren von atp-bindenden kassettentransportern
EP1951197A4 (de) * 2005-11-10 2011-12-21 Alphapharm Pty Ltd Verfahren zur kontrolle der teilchengrösse
AU2006313009B2 (en) * 2005-11-10 2013-10-24 Alphapharm Pty Ltd Process to control particle size
WO2007089926A2 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
CA2630240A1 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
EP2010499A4 (de) * 2006-04-21 2012-07-18 Alphapharm Pty Ltd Pharmazeutische zusammensetzungen von oxcarbazepin mit einer medianen teilchengrösse von 15 bis 30 mikron
WO2007122635A2 (en) 2006-04-26 2007-11-01 Astron Research Limited Controlled release formulation comprising anti-epileptic drugs
ES2360423T3 (es) * 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
JP2010513324A (ja) 2006-12-21 2010-04-30 アルファファーム ピーティーワイ リミテッド 医薬化合物および医薬組成物
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP1970056A1 (de) * 2007-03-15 2008-09-17 Polichem S.A. Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung
EP2146699A2 (de) * 2007-05-23 2010-01-27 Ratiopharm GmbH Pharmazeutische zusammensetzungen mit oxcarbazepin
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
SI2225230T1 (sl) 2007-12-07 2017-03-31 Vertex Pharmaceuticals Incorporated Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
HRP20211752T1 (hr) 2010-04-07 2022-02-18 Vertex Pharmaceuticals Incorporated Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
WO2013112804A1 (en) 2012-01-25 2013-08-01 Vertex Pharmaceuticals Incorporated Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
JP6963896B2 (ja) 2013-11-12 2021-11-10 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Ｃｆｔｒ媒介性疾患の処置のための医薬組成物を調製する方法
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TW202444706A (zh) 2019-05-16 2024-11-16 瑞士商諾華公司 N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
JPS6257467A (ja) * 1985-09-06 1987-03-13 Asahi Glass Co Ltd コ−テイング剤組成物
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5478654A (en) * 1994-05-06 1995-12-26 Gencorp Inc. Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Also Published As

Publication number Publication date
MY117582A (en) 2004-07-31
KR20090037873A (ko) 2009-04-16
NO993919D0 (no) 1999-08-13
TW529957B (en) 2003-05-01
SK284503B6 (sk) 2005-05-05
DK0966287T3 (da) 2003-08-25
CA2277791A1 (en) 1998-08-20
TR199901804T2 (xx) 1999-09-21
HUP0000886A3 (en) 2002-10-28
ZA981205B (en) 1998-08-14
BR9807368A (pt) 2000-03-14
CN1626093A (zh) 2005-06-15
HK1024423A1 (en) 2000-10-13
AU6622298A (en) 1998-09-08
US20080014269A1 (en) 2008-01-17
EP0966287B1 (de) 2003-05-07
AR011142A1 (es) 2000-08-02
CZ298840B6 (cs) 2008-02-20
KR20120079826A (ko) 2012-07-13
NO327486B1 (no) 2009-07-13
CZ287999A3 (cs) 1999-11-17
PL193332B1 (pl) 2007-02-28
PT966287E (pt) 2003-09-30
WO1998035681A1 (en) 1998-08-20
AU738030B2 (en) 2001-09-06
CO4920215A1 (es) 2000-05-29
US20070036863A1 (en) 2007-02-15
EP0966287A1 (de) 1999-12-29
JP2010132694A (ja) 2010-06-17
CA2277791C (en) 2008-11-18
HUP0000886A2 (hu) 2000-09-28
HU227807B1 (en) 2012-03-28
CY2480B1 (en) 2005-06-03
ES2199422T3 (es) 2004-02-16
JP2000511935A (ja) 2000-09-12
ID22348A (id) 1999-09-30
JP2006077029A (ja) 2006-03-23
NZ336946A (en) 2001-02-23
KR19980071337A (ko) 1998-10-26
NO993919L (no) 1999-08-13
UY24888A1 (es) 2000-12-29
CN1170542C (zh) 2004-10-13
PE58999A1 (es) 1999-06-25
DE69814367T2 (de) 2004-02-26
DE69814367D1 (de) 2003-06-12
RU2201218C2 (ru) 2003-03-27
PL334959A1 (en) 2000-03-27
SK109899A3 (en) 2000-03-13
CN1247471A (zh) 2000-03-15

Similar Documents

Publication Publication Date Title
ATE239481T1 (de) Filmueberzogene tabletten von oxacarbazepin
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69802187D1 (de) Mullit enthaltende schleifgegenstände
DE69805692D1 (de) Uhrenarmband
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ID23874A (id) Obat
DK0737738T3 (da) Blegemiddeltablet
DE69820407D1 (de) Blisterpackung
NO980546D0 (no) Farmasöytiske midler
DE69822555D1 (de) Schuhwerk
DK1017392T3 (da) Lægemiddel
DE69730599D1 (de) Waschmitteltablette
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
FI974067A0 (fi) Process foer cellulasbehandling
FI973622L (fi) Pilarikenkä
KR970008018U (ko) 장제용 위패
DE69834398D1 (de) Anhänger
DK0862964T3 (da) Svejsebolte
KR970026641U (ko) 부츠
FR2772264B1 (fr) Pilulier
DE59804072D1 (de) Zähler
FI980126L (fi) Pohjallinen
ID21180A (id) Senyawa-senyawa farmasi
ES1036889Y (es) Pulsera
UA2072S (uk) Набір блюд

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966287

Country of ref document: EP

RZN Patent revoked